Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
7.95
-0.07 (-0.87%)
Sep 8, 2026, 4:00 PM EDT - Market closed
Harvard Bioscience Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 87.81 | 86.55 | 94.14 | 112.25 | 113.34 | 118.9 |
Revenue Growth | -1.06% | -8.06% | -16.14% | -0.96% | -4.68% | 16.46% |
Gross Profit Gross Profit Growth | 51.07 | 49.91 | 54.81 | 66.39 | 62.29 | 67.65 |
Operating Income Operating Income Growth | 1.97 | 1.5 | -4.72 | 2.5 | -5.19 | 3.69 |
Net Income Net Income Growth | -10.41 | -56.7 | -12.41 | -3.42 | -9.52 | -0.29 |
Earnings Per Share EPS Growth | -2.35 | -12.80 | -2.85 | -0.81 | -2.30 | -0.10 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 38.79 | 38.97 | 41.74 | 48.21 | 49.91 | 49.83 |
Americas - Other Americas - Other Growth | 3.7 | 3.23 | 3.6 | 3.52 | - | - |
Europe, Middle East and Africa Europe, Middle East and Africa Growth | 27.35 | 26.71 | 28.41 | 33.28 | - | - |
China China Growth | 11.67 | 10.97 | 13.3 | 18.49 | 16.39 | 13.5 |
Asia - Other Asia - Other Growth | 6.3 | 6.68 | 7.1 | 8.77 | - | - |
Total Total Growth | 87.81 | 86.55 | 94.14 | 112.25 | 113.34 | 118.9 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 6.5 | 8.61 | 4.11 | 7.78 | 4.51 | 7.82 |
Total Debt Total Debt Growth | 44.21 | 44.28 | 44.59 | 42.97 | 54.24 | 56.96 |
Net Cash (Debt) Net Cash Growth | -37.7 | -35.66 | -40.49 | -35.19 | -49.73 | -49.14 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -8.43 | -8.03 | -9.30 | -8.30 | -12.01 | -12.18 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 0.65 | 6.73 | 1.44 | 14.03 | 1.15 | 1.26 |
Capital Expenditures CapEx Growth | -1.77 | -1.26 | -2.64 | -1.79 | -1.59 | -1.2 |
Free Cash Flow Free Cash Flow Growth | -1.12 | 5.47 | -1.2 | 12.24 | -0.44 | 0.07 |
Free Cash Flow Growth | - | - | - | - | - | -99.18% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 58.16% | 57.67% | 58.22% | 59.15% | 54.96% | 56.90% |
Operating Margin | 2.25% | 1.73% | -5.01% | 2.22% | -4.58% | 3.10% |
Pretax Margin | -12.00% | -66.30% | -12.39% | -2.28% | -8.10% | -0.12% |
Profit Margin | -11.86% | -65.51% | -13.18% | -3.04% | -8.40% | -0.24% |
FCF Margin | -1.27% | 6.32% | -1.28% | 10.90% | -0.39% | 0.06% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | 44.17 | 7.87 | 17.58 | 23.26 | 17.87 | 22.03 |
P/FCF Ratio | - | 5.45 | - | 18.66 | - | 4294.24 |
PS Ratio | 0.41 | 0.34 | 0.98 | 2.04 | 1.02 | 2.42 |